Connected With Latham
Autor: Latham & Watkins
In each episode of Connected With Latham, we discuss ideas, developments, and trends shaping the global economy.
Odcinki
- Drug Pricing and Market Access: Takeaways from the Medicaid Drug Rebate Program Summit 2026 – Connected With Latham
- The Growth Rocketship: Deep Research, Bold Bets, and AI — Inside Maverick Capital's $15 Billion Portfolios – Connected With Latham
- Shining a Light on the Sunshine Act and Transparency Requirements: A Primer for Life Sciences Companies – Connected With Latham
- Drug Pricing and Market Access: The RAPID Pathway – Connected With Latham
- The Growth Rocketship: Brave Capital, Defense Tech, Decisive Technologies! – Connected With Latham
- The Growth Rocketship: Hercules Backs Tech, Life Sciences – Connected With Latham
- Europe Litigation: Mass Actions at a Global Scale – Connected With Latham
- The Growth Rocketship: Inside Boutique Venture With NewView Capital – Connected With Latham
- The Growth Rocketship: Modernizing Real Estate With Opendoor – Connected With Latham
- The Growth Rocketship: How Rakuten Capital Masters Diplomatic Capitalism – Connected With Latham
- The Growth Rocketship: Axiado Takes Cybersecurity Inside the Rack – Connected With Latham
- The Growth Rocketship: Using AI to Accelerate Analog Semiconductor Design With Celera – Connected With Latham
- Drug Pricing and Market Access: CMS Update With Rujul Desai – Connected With Latham
- Drug Pricing and Market Access: Highlights From Recent CMS and AHLA Conferences – Connected With Latham
- The Growth Rocketship: Using AI and Human Expertise to Build Tomorrow's Leading Brands With A-Frame – Connected With Latham
- Helping Holocaust Survivors – Connected With Latham
- The Growth Rocketship: Navigating the Institutional Evolution of the Blockchain World With ParaFi – Connected With Latham
- The Growth Rocketship: The Future of Rewards-Based Advertising With Fetch – Connected With Latham
- Spotlight on US State Healthcare Transaction Review Laws – Connected With Latham
- Drug Pricing and Market Access: Key Takeaways From 2025 and Outlook for 2026 – Connected With Latham
- UK FinReg Focus Areas in 2026 – Connected With Latham
- Drug Pricing and Market Access: "Think of It as a Loop" — Succeeding in an Evolving Policy Landscape – Connected With Latham
- The FDA's New Playbook: Biosimilars, National Priority Vouchers, and the Plausible Mechanism Pathway – Connected With Latham
- Drug Pricing and Market Access: Government Pricing Assessment Expectations and Benefits – Connected With Latham
- Drug Pricing and Market Access: Deep Dive on the FDA Commissioner's National Priority Voucher Program Awards – Connected With Latham
- Drug Pricing: Takeaways from the Chicago Medicaid Drug Rebate Program Summit – Connected With Latham
- EU Data Act: Spotlight on Switching Requirements for Data Processing Services – Connected With Latham
- EU Data Act: Implications for Data Privacy and Cybersecurity – Connected With Latham
- The Leeds Reforms: Implications for UK Financial Services – Connected With Latham
- Drug Pricing: Takeaways from the Philadelphia Pricing and Contracting USA Conference – Connected With Latham